BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10411338)

  • 1. Proteasome-dependent degradation of p27/kip1 in gliomas.
    Piva R; Cancelli I; Cavalla P; Bortolotto S; Dominguez J; Draetta GF; Schiffer D
    J Neuropathol Exp Neurol; 1999 Jul; 58(7):691-6. PubMed ID: 10411338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot.
    Schiffer D; Cavalla P; Fiano V; Ghimenti C; Piva R
    Neurosci Lett; 2002 Aug; 328(2):125-8. PubMed ID: 12133571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p27/kip1 expression in oligodendrogliomas and its possible prognostic role.
    Cavalla P; Piva R; Bortolotto S; Grosso R; Cancelli I; ChiĆ² A; Schiffer D
    Acta Neuropathol; 1999 Dec; 98(6):629-34. PubMed ID: 10603039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
    Loda M; Cukor B; Tam SW; Lavin P; Fiorentino M; Draetta GF; Jessup JM; Pagano M
    Nat Med; 1997 Feb; 3(2):231-4. PubMed ID: 9018245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2.
    Nakamura M; Matsuo T; Stauffer J; Neckers L; Thiele CJ
    Cell Death Differ; 2003 Feb; 10(2):230-9. PubMed ID: 12700651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
    Lu Y; Zi X; Pollak M
    Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27/kip1 expression in human astrocytic gliomas.
    Piva R; Cavalla P; Bortolotto S; Cordera S; Richiardi P; Schiffer D
    Neurosci Lett; 1997 Oct; 234(2-3):127-30. PubMed ID: 9364514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying nonsteroidal anti-inflammatory drug-induced p27(Kip1) expression.
    Huang YC; Chuang LY; Hung WC
    Mol Pharmacol; 2002 Dec; 62(6):1515-21. PubMed ID: 12435820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
    Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
    Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells.
    Eguchi H; Herschenhous N; Kuzushita N; Moss SF
    Cancer Res; 2003 Aug; 63(15):4739-46. PubMed ID: 12907657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
    Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
    Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
    Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
    Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
    Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
    Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.
    Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S
    Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.